Ardelyx News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.12.17	PTI Gaining Ground, LENS Looks Brighter, Busy Year Ahead For CNAT (RTTNews)
11.12.17	Ardelyx Announces License Agreement with Shanghai Fosun Pharmaceutical Industrial Development Company Limited for Tenapanor in China (PR Newswire)
29.11.17	APEN Gains Steam, SGRY Starting To Heal, AZRX Catches Eyes, No Stopping CPRX (RTTNews)
28.11.17	Ardelyx and Kyowa Hakko Kirin Announce License Agreement for Tenapanor for Cardiorenal Diseases in Japan (PR Newswire)
22.11.17	First 2-drug HIV Regimen Gets FDA Nod, Starpharma Shines, ARDX Drops RDX7675 (RTTNews)
21.11.17	Ardelyx Announces Updated Development Path for its Cardiorenal Pipeline (PR Newswire)
07.11.17	Ardelyx Reports Third Quarter 2017 Operating Results and Clinical Progress (PR Newswire)
18.10.17	VYGR Cruises Ahead, APVO On Track, ARDX Continues To Fall, AGRX On Watch (RTTNews)
17.10.17	HIIQ In Good Health, BOLD Awaits ASPIRO Data, CELESTIAL Lights Up EXEL (RTTNews)
16.10.17	Ardelyx Announces Tenapanor Reduces Pain Caused by IBS-C Through Inhibition of TRPV-1 Signaling (PR Newswire)
13.10.17	INFI Turns Heads, ARDX Marches On, VYGR Cruises Ahead, ACRX Disappoints (RTTNews)
12.10.17	ARDX Surges After-hours, MBVX Abuzz, TRVN Keeps Its Focus (RTTNews)
11.10.17	Ardelyx's Pivotal Phase 3 Study of Tenapanor for IBS-C Hits Primary and All Secondary Endpoints to Support NDA Submission in 2018 (PR Newswire)
03.10.17	ECYT On Fire After ABX Deal, Rigel's ITP Drug Skips Panel Review, MCRB On Watch (RTTNews)
09.08.17	Ardelyx Focuses Resources on Late-Stage Programs and Reports Second Quarter 2017 Operational Results (PR Newswire)
26.06.17	Biotech Stock Performance Review -- Alder Biopharma, Ardelyx, Bellerophon Therapeutics, and Corbus Pharma (PR Newswire)
14.05.17	AZN's PACIFIC Proves To Have Depth, ARDX Abuzz, No Flashy Data From ALLSTAR (RTTNews)
12.05.17	Ardelyx Reports Successful Phase 3 T3MPO-1 Trial of Tenapanor in Patients with IBS-C (PR Newswire)
05.05.17	Ardelyx Reports First Quarter 2017 Operating Results and Highlights Recent Progress (PR Newswire)
18.04.17	Ardelyx To Present at Upcoming Spring Medical Meetings (PR Newswire)
27.02.17	Ardelyx Announces Presentation at Cowen and Company 37th Annual Healthcare Conference (PR Newswire)
17.02.17	Ardelyx Reports Clinical Progress and Fourth Quarter and Full Year 2016 Financial Results (PR Newswire)
16.02.17	ARDX Kidney Drug Passes Phase 3 Study, EDIT Up On CRISPR News, FDA Nod For VRX (RTTNews)
16.02.17	Gainers & Losers Of The Day: ZSAN, EVOK, ARDX, EARS, NEOT... (RTTNews)
15.02.17	Ardelyx Announces Successful Phase 3 Trial of Tenapanor for Hyperphosphatemia in Patients with End-Stage Renal Disease (PR Newswire)
06.01.17	Gainers & Losers Of The Day: ETRM, PIRS, GNVC, AEZS, XXII (RTTNews)
04.01.17	AGRX Fails To SECURE Investor Confidence, ITEK Hit Hard, CBAY Rises On Kowa Deal (RTTNews)
03.01.17	Ardelyx Announces Initiation of Two Clinical Trials for RDX7675 for Treatment of Hyperkalemia (PR Newswire)
22.06.16	Ardelyx Reports Positive Results From End-of-Phase 2 Meeting With FDA (RTTNews)
07.03.16	TNXP Awaits Data In Q2, LLY Uncovers Ixekizumab's Potential, High Five For MNOV (RTTNews)
02.09.15	FLXN On Fast Track, WMGI Gets FDA Nod, RDHL Gearing Up, NVRO Awaits D-Day (RTTNews)
04.06.15	BLUE, CELG Fine Tune Deal, Lightlake Cruises Ahead, HALO Shines, CPXX On Track (RTTNews)
03.06.15	Ardelyx Terminates Agreement With AstraZeneca; Regains Rights To Tenapanor (RTTNews)
13.05.15	ARDX To Meet With FDA, VRTX Gains In After-Hours, Watch Out For AQXP (RTTNews)
06.05.15	ARDX Knocked Down, Expanding Uses Of Humira, ALDR Passes Arthritis Drug Trial (RTTNews)
06.05.15	Ardelyx Plunges As Phase 2A Study Of Tenapanor Fails Primary Point (RTTNews)
05.05.15	After-market Movers For May 5 (EA, HLF, BRDR, ICUI, GRPN, NDLS, ZU, ARDX) (RTTNews)
02.02.15	Ardelyx Reports Results From Phase 2b Trial Of Tenapanor In Hyperphosphatemia (RTTNews)
02.10.14	ARDX Surges On Study Data, HBIO Opens Wallet, ZGNX On Watch, PTLA Creates Buzz (RTTNews)
01.10.14	Ardelyx Phase 2b Trial Of Tenapanor Meets Primary Endpoint (RTTNews)
07.08.14	Ardelyx Turns To Profit In Q2 (RTTNews)
19.06.14	Ardelyx Prices IPO At $14/Shr, Midpoint Of Expected Range (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.14	1.54 %	K V
UBS Group	28.08	1.48 %	K V
Swiss Re	130.05	1.05 %	K V
Part Grp Hldg	1’266.00	0.96 %	K V
ABB	49.48	0.94 %	K V
Geberit	525.20	0.27 %	K V
Alcon	78.04	0.05 %	K V
Givaudan	3’868.00	-0.31 %	K V
CieFinRichemont	121.20	-0.57 %	K V
Sonova Hldg	301.00	-0.99 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Ardelyx Inc

Aktien Top/Flop

Meistgelesene Nachrichten